Melola Discovery

← Melola Discovery

Jurnal Tanpa peringkat SINTA

Hematopoietic Effects of Chemotherapy in Pediatric Patients with Acute Lymphoblastic Leukemia: A Systematic Review

Jambi Medical Journal : Jurnal Kedokteran dan Kesehatan · Vol. 14 No. 1 (2026) · hlm. 51–60

DOI
10.22437/jmj.v14i1.50099
ISSN
2580-6874, 2339-269X
Terbit
2026-05-14
Penerbit
FAKULTAS KEDOKTERAN DAN ILMU KESEHATAN UNIVERSITAS JAMBI
Bahasa
en

Abstrak

Background: Chemotherapy is the mainstay of treatment for pediatric acute lymphoblastic leukemia (ALL) but is frequently associated with significant hematopoietic suppression. This systematic review aimed to evaluate the effects of chemotherapy on hematopoietic suppression and recovery in pediatric patients with acute lymphoblastic leukemia. Methods: This systematic review was registered in PROSPERO (CRD420251074627) and conducted according to PRISMA 2020 guidelines. Literature searches were performed in PubMed, ScienceDirect, and SpringerLink for studies published between 2020 and 2025. Original studies assessing chemotherapy-related hematopoietic changes in pediatric ALL were included. After screening titles, abstracts, and full texts, 7 studies were eligible and synthesized narratively. Results: Induction chemotherapy consistently caused profound suppression of erythropoiesis, granulopoiesis, and thrombopoiesis, reflected by declines in hemoglobin, absolute neutrophil counts, and platelet counts. Hematopoietic recovery was phase-specific and lineage-dependent, with earlier erythroid recovery compared with neutrophil and platelet recovery. Early markers, including reticulocyte indices and immature platelet fraction, demonstrated earlier recovery than conventional blood counts. Bone marrow assessments showed delayed restoration of marrow cellularity and hematopoietic stem cell compartments despite morphologic remission. Conclusion: Chemotherapy-induced hematopoietic suppression in pediatric ALL is marked and heterogeneous, with recovery extending beyond morphologic remission. Integrated monitoring using peripheral blood parameters, early recovery markers, and selective bone marrow evaluation may improve assessment of hematopoietic recovery and supportive care during treatment

Kata kunci

Jaringan kolaborasi para penulis

2 penulis · 1 tautan kepenulisan bersama

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://online-journal.unja.ac.id/index.php/kedokteran/oai, pertama di-harvest 6 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Hematopoietic Effects of Chemotherapy in Pediatric Patients with Acute Lymphoblastic Leukemia: A Systematic Review</dc:title>
	<dc:creator xml:lang="en">Primartati, Danny Meganingdyah</dc:creator>
	<dc:creator xml:lang="en">Fatmariza, Aulia Risqi</dc:creator>
	<dc:subject xml:lang="en">ALL Pediatric</dc:subject>
	<dc:subject xml:lang="en"> Effect Chemotherapy</dc:subject>
	<dc:subject xml:lang="en">; Hematopoietic Suppression</dc:subject>
	<dc:subject xml:lang="en"> Induction Phase</dc:subject>
	<dc:description xml:lang="en">Background: Chemotherapy is the mainstay of treatment for pediatric acute lymphoblastic leukemia (ALL) but is frequently associated with significant hematopoietic suppression. This systematic review aimed to evaluate the effects of chemotherapy on hematopoietic suppression and recovery in pediatric patients with acute lymphoblastic leukemia.
Methods: This systematic review was registered in PROSPERO (CRD420251074627) and conducted according to PRISMA 2020 guidelines. Literature searches were performed in PubMed, ScienceDirect, and SpringerLink for studies published between 2020 and 2025. Original studies assessing chemotherapy-related hematopoietic changes in pediatric ALL were included. After screening titles, abstracts, and full texts, 7 studies were eligible and synthesized narratively.
Results: Induction chemotherapy consistently caused profound suppression of erythropoiesis, granulopoiesis, and thrombopoiesis, reflected by declines in hemoglobin, absolute neutrophil counts, and platelet counts. Hematopoietic recovery was phase-specific and lineage-dependent, with earlier erythroid recovery compared with neutrophil and platelet recovery. Early markers, including reticulocyte indices and immature platelet fraction, demonstrated earlier recovery than conventional blood counts. Bone marrow assessments showed delayed restoration of marrow cellularity and hematopoietic stem cell compartments despite morphologic remission.
Conclusion: Chemotherapy-induced hematopoietic suppression in pediatric ALL is marked and heterogeneous, with recovery extending beyond morphologic remission. Integrated monitoring using peripheral blood parameters, early recovery markers, and selective bone marrow evaluation may improve assessment of hematopoietic recovery and supportive care during treatment</dc:description>
	<dc:publisher xml:lang="en">FAKULTAS KEDOKTERAN DAN ILMU KESEHATAN UNIVERSITAS JAMBI</dc:publisher>
	<dc:date>2026-05-14</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://online-journal.unja.ac.id/kedokteran/article/view/50099</dc:identifier>
	<dc:identifier>10.22437/jmj.v14i1.50099</dc:identifier>
	<dc:source xml:lang="en">Jambi Medical Journal : Jurnal Kedokteran dan Kesehatan; Vol. 14 No. 1 (2026): JAMBI MEDICAL JOURNAL: Jurnal Kedokteran dan Kesehatan; 51-60</dc:source>
	<dc:source>2580-6874</dc:source>
	<dc:source>2339-269X</dc:source>
	<dc:language>en</dc:language>
	<dc:relation>https://online-journal.unja.ac.id/kedokteran/article/view/50099/24331</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2026 Jambi Medical Journal : Jurnal Kedokteran dan Kesehatan</dc:rights>
</oai_dc:dc>